These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 854230)

  • 21. Immune monitoring of cancer patients undergoing experimental immunotherapy.
    Shankar G; Salgaller ML
    Curr Opin Mol Ther; 2000 Feb; 2(1):66-73. PubMed ID: 11249653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunodiagnosis and its relevance in neoplastic disease, immunotherapy in neoplastic disease].
    Kreienberg R
    Gynakologe; 1990 Jun; 23(3):122-9. PubMed ID: 2201596
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of immune processes on the growth and regression of malignant tumors].
    Russo V; Russo L
    Vopr Onkol; 1974; 20(6):68-75. PubMed ID: 4603500
    [No Abstract]   [Full Text] [Related]  

  • 24. [Problems of the immunotherapy of malignant neoplasma].
    Trapeznikov NN; Iavorskiĭ VV
    Klin Med (Mosk); 1975 May; 52(5):15-22. PubMed ID: 1094178
    [No Abstract]   [Full Text] [Related]  

  • 25. Current condition and prognosis of tumor immunotherapy: a second opinion.
    Mastrangelo MJ; Berd D; Maguire HC
    Cancer Treat Rep; 1984 Jan; 68(1):207-19. PubMed ID: 6362864
    [No Abstract]   [Full Text] [Related]  

  • 26. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas.
    Lee Y; Bigner DD
    Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic aspects of malignancy: Factors of concern in the prospective candidate for immunotherapy.
    Ablin RJ
    Allergol Immunopathol (Madr); 1975; 3(2):105-8. PubMed ID: 1155313
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cell therapy in solid tumors].
    Ravaud A
    Bull Cancer; 2001 Jan; 88(1):91-100. PubMed ID: 11182658
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel antigenic markers of human tumor regression.
    Fareed GC; Mendiaz E; Sen A; Juillard GJ; Weisenburger TH; Totanes T
    J Biol Response Mod; 1988 Feb; 7(1):11-23. PubMed ID: 3373233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro methods for assessment of antibody-mediated tumor immunity.
    Levy NL; Amos DB; Solovieff GV; dos Reis AP
    Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154
    [No Abstract]   [Full Text] [Related]  

  • 31. [Attempts at immunologic therapy in cancer].
    Chenebault J
    Maroc Med; 1974 Jun; 54(580):385-8. PubMed ID: 4408626
    [No Abstract]   [Full Text] [Related]  

  • 32. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunology of melanoma].
    Vanwijck R; Bernheim JL; Lejeune FJ
    Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
    [No Abstract]   [Full Text] [Related]  

  • 34. Targeted cellular immunotherapy with bifunctional antibodies.
    Nelson H
    Cancer Cells; 1991 May; 3(5):163-72. PubMed ID: 1832553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemo- and immunotherapy of malignant neoplasms].
    Matthias M
    Z Arztl Fortbild (Jena); 1975 Jun; 69(11):580-4. PubMed ID: 1065149
    [No Abstract]   [Full Text] [Related]  

  • 36. The natural history of the antibody response to breast antigens.
    Boehm OR; Boehm BJ; Humphrey LJ
    Clin Exp Immunol; 1974 Jan; 16(1):31-9. PubMed ID: 4219760
    [No Abstract]   [Full Text] [Related]  

  • 37. Radiodiagnostic and radiotherapeutic implications of the recent discovery of a common malignant tumour antigen, CTA, absolutely unique to cancer cells.
    Kast RE
    Radiobiol Radiother (Berl); 1977; 18(4):536-44. PubMed ID: 601218
    [No Abstract]   [Full Text] [Related]  

  • 38. Monoclonal antibodies and immunologic approaches to malignant tumors.
    Ng AK; Giacomini P; Ferrone S
    Adv Intern Med; 1983; 28():253-76. PubMed ID: 6340428
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunology of malignant melanoma].
    Misgeld V
    Hautarzt; 1973 Dec; 24(12):511-9. PubMed ID: 4599321
    [No Abstract]   [Full Text] [Related]  

  • 40. The immunotherapy of cancer.
    Parker CW
    Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.